[Aminopenicillin rashes - a multicentric prospective study (author's transl)].


538 patients, admitted to the hospitals participating in this study for a variety of indications for antibacterial therapy, were treated by the ampicillin-analogue Epicillin. 42 patients (7.8%) who developed exanthem underwent detailed clinical and immunological investigation. Exanthems were scored according to the form of application and doses of Epicillin… (More)


  • Presentations referencing similar topics